The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN